Combe divests Cough/Cold, Skin Care and Foot Care businesses

Combe Incorporated, ("Combe") today announced that it has completed the sale of its Cough/Cold, Skin Care and Foot Care businesses.

The Cough/Cold and Skin Care businesses, including the Cepacol®, Lanacane®, Scalpicin®, LiceMD®, and Hemoal® brands, have been sold to Reckitt Benckiser Inc.

The Foot Care business, consisting of the Odor-Eaters® brand, has been sold to Blistex Inc.

"We are very proud of our divested businesses and are excited about the future of these brands.  More importantly, these divestitures enable us to increase our company-wide focus on our largest global brands," explains Christopher B. Combe, Chairman and CEO.  "Our retained brands have strong growth opportunities around the world supported by positive demographic shifts, our leadership positions in these categories, and a pipeline of innovative and potentially game-changing new products."

Morgan Stanley & Co. Incorporated served as financial advisor and Sullivan & Cromwell LLP served as legal advisor to Combe in connection with these transactions.

SOURCE Combe Inc.